ABSTRACT. \Ye used an immunoperoxidasc method to examine the exprcssion of the immune activation marker HLA-DR on pulmonary tissue obtained at autopsy from 14 patients dying of bronchopulmonary dysplasia. Controls consisted of 16 age-matched, sex-matched children dying of noncardiac, nonrespiratory, noninfectious illnesses or a s a result of motor vehicle accidents. \Ve did not observe aberrant expression of IILA-DR on pulmonary endotllclial cells. Positive staining appeared exclusively on macrophages. \Ye quantitated the expression of antigen by counting the number of positive macrophages and total macrophages/monocytes per high power field. Bronchopulmonary dysplasia patients displayed significantly greater numbers of both positive and total macrophages compared with the control group ( p < 0.05). The percent positive macrophages also was significantly higher in the bronchopulmonary dysplasia patients ( p < 0.005). \Ye also examined a group of paticnts dying with infant respiratory distress syndrome. 'There was no significant difference in number of total macrophages in this group compared with age-matched controls. can be induced or increased on cell surfaces by exposure of the cell to certain lymphokines, most notably by . Several studies suggest that the aberrant expression of MHC molecules on highly differentiated target cells increases susceptibility to immune destruction (6, 7). Several studies have demonstrated increased or aberrant expression of MHC class I1 markers on the surfaces of alveolar macrophages in various pulmonary disorders. T o date, there are no similar studies in patients with BPD.
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In the present study, we sought it1 silrr evidence of immune activation or altered immunogenicity in lungs of patients with BPD. We used an anti-HLA-DR antibody to study the presence of aberrant or increased expression of MHC class I1 molecules on pulmonary endothelial and macrophage cell surfaces, a finding that could provide evidence for an immune activation process as part of the pathophysiology of BPD.
MATERIALS A N D METHODS
I'cirict~rs. Patients were selected by review of autopsy records from 1976 t o 1989 at Children's Hospital and Medical Center, Seattle, WA. We studied 14 consecutive patients who met all study criteria and whose lung tissue was available for study. Our study ~a t i e n t s were former uremature infants whose primary causc of death was progressi;e respiratory failure secondary to BPD. Gestational ages and birth weights are listcd in Table 1 . BPD was defined by clinical, radiographic, and pathologic crite-BPD is a constellation of clinical. radiographic. and pathologic changes that occurs in some premature infants, usually after infant respiratory distress syndrome. Chronologic pathologic studies of the disease reveal a n initial pattern of alveolar and epithelial damage that progresses to an inflammatory process followed by interstitial fibrosis. Macrophages and other leukocytes are prominent in the damaged airways and submucosa, but their contribution to the pathogenesis of BPD remains unknown (I). Class I1 major histocompatibility molecules (HLA-DR. HLA-DP, and HLA-DQ antigens in humans, or la antigens) are cell surface molecules constitutively expressed only o n B lymphocytes, macrophages, vascular endothelial cells, and on other ria. Patients who were culture positive for bacterial o r viral pathogens at the time of death or on autopsy tissue were excluded. as were any culture-negative paticnts whose pulmonary tissue demonstrated the presence of bacteria by histologic examination. We also excluded patients with chromosomal anomalies and those who had received steroids. Our patient group consisted of I0 males and four females. They ranged in age from 1 to I3 mo (mean age, 5.2 mo). Age-matched controls were selected from motor vehicle accident victims in the 1985 to 1988 autopsy files at the King County Medical Examiner's Office. They consisted of I I males and five females, ranging in age from 1 to 12 mo (mean age, 6.0 mo) ( Table 2 ). We also examined seven patients dying from respiratory failure secondary to infant respiratory distress syndrome who met our exclusion criteria for BPD. Their ages ranged from I to 17 d (Table 3) .
.
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Lung tissue was obtained at autopsy and was formalin-fixed and wax embedded. Lung sections 4 to 5 pm in thickness were placed on acid-washed slides and dried over- Imrn~rt~o/~i.stoc/~~~t?~i.rtr~~. Tissue was stained using a standard three-stage immunoperoxidase technique (9, 10). Specimens were first deparafinized using xylene, then rehydrated using a series of graded alcohol. After rinsing in distilled water, endogenous peroxidase activity was quenched using a 30-min incubation with 0.3% HzOz in methanol. Samples were rinscd and then incubated for 20 rnin with dilute normal serum to block nonspecific binding. Excess serum was blotted from specimens. Spccimens were incubated for 30 min with a 1 5 0 dilution of primary antibody M474 diluted 1 5 0 in PBS. Slides were rinsed twice with PBS. Samples were then incubated for 30 min with dilute affinity-purified biotinylated antibody. After two washes. slides were incubated for 60 rnin with avidin/horseradish peroxidase.
Slides were washed and incubated for 2 to 7 min with 3.3' diamino-benzidine substrate. Slides were rinscd and then counterstained with 1% methyl green for 2 min. Slides were again washed and then dehydrated by a series of alcohol changes before mounting. Each assay included a set of positive control slides consisting of tonsillar tissue. Lymphoid cells in these slides were invariably darkly stained. Each sample was run in parallel with a negative control slide to which n o primary antibody was added. Slides were run in duplicate on separate days up to four times. Interassay variation was minimal. We did not attempt to control for differences in expansion of lung.
Rcc~cling uf slilles. Slides were read in a blinded fashion.
Macrophages were identified by their distinctive morphologic characteristics. Four slides were prepared from each patient's available lung tissue for replicate assays for each patient. Slides were scanned on low power to identify areas of positive staining. In each area of positive staining, three representative hpf were counted. Positive macrophages were identified as those that exhibited bright staining comparable to positive control tonsillar tissue. Each patient reported as having 0 positive macrophages had no identifiable activated macrophages with low power scanning in any of the air space or parenchymal areas of any of the slides. Each slide stained with anti-HLA-DR was compared with a control slide stained without the primary antibody. Macrophages were quantitated as the number per hpf. Readings from separate experiments were averaged. S~urisricul anul~~sis. The number of positive macrophages in each group was compared using the Mann-Whitney rank sum test for unpaired samples. The proportion of patients in each group displaying more than 1 positive macrophage per hpf was analyzed using the Fisher exact test. The numbers of total macrophages followed a normal distribution and so were analyzed using a t test for unpaired samples.
RESULTS
We did not observe aberrant expression of HLA-DR on pulmonary endothelial cells. Positive-stained cells consisted entirely of macrophages as identified by histologic examination (Fig. 1) .
Patients with BPD displayed a mean of 6.2 + 7.1 positive macrophages/hpf compared with 0.725 + 1.34 positive macrophages/hpf in the control group ( p < 0.05, Fig. 2) . The proportion of patients displaying more than I macrophage/hpf was significantly higher in the BPD group (nine of 14) compared with controls (three of 16) ( p < 0.005). Macrophages in BPD patients were noted to be larger and to contain more vacuoles than macrophages from control patients. The total number of The percent positive macrophages was 17.7 and 4.8% for patients and controls, respectively (Fig. 3) . A separate group consisting of seven patients dying of infant respiratory distress syndrome was found to have numbers of positive macrophages (1.23 + 1.241 hpf) and total macrophages (28.1 f 22.7/hpf) that were not significantly different from the control group.
Two distinct groups were noted within the BPD patients: those with fewer than three macrophages per hpf, and those with more than seven macrophages per hpf. There were n o differences in mean age at death or sex distribution between these two subgroups of infants with BPD. However, there was a trend toward greater gestational age at birth in the infants with BPD who had more than seven macrophages per hpf. Although it is possible that those patients with large numbers of macrophages were subclinically infected, no bacterial or viral cultures obtained around the time of death yielded any pathogen. Further, there was n o histologic evidence of infection in any of the infants.
DISCUSSION
The present study demonstrates a significant increase in the total number of macrophages and of activated macrophages in the lungs in BPD patients compared with the control population. Although the present results are similar to previous reports demonstrating that alveolar macrophages obtained by bronchial lavage in various disease conditions display increased density of MHC class I1 molecules (1 1, 12), a criticism of these previous studies has been that the macrophages obtained by lavage may not appropriately reflect the cell populations present in siilr. By taking advantage of an MAb that binds formalin-fixed, waxembedded tissue, we were able to examine tissue in situ, comparing an appropriate control group to lung sections of infants dying of the most common chronic pulmonary sequelae of prematurity.
We considered the possibility that the positive results may represent nonspecific binding of primary antibody by the Fc receptor of the macrophage. This is unlikely because the patient population displayed significant binding whereas the controls did not. However, it is known that activation of macrophages leads to an increase in density of Fc receptor on the cell surface (13, 14) . Thus, we may have been observing a separate marker of macrophage activation in our patients that was unrelated to HLA-DR. We eliminated this possibility by demonstrating that macrophages were not stained by an irrelevant IgG 1.
We were interested initially in the possibility of aberrant expression of HLA-DR on endothelial or on other specialized cell surfaces. In studies of diabetes, insulin-producing cells but not glucagon-or somatostatin-producing cells aberrantly express MkIC class I1 early in the time course of autoimmune attack. The local capillary endothelium in the pancreas also has been shown t o be strongly HLA-DR positive (15). A study of fibrosing alveolitis demonstrated the aberrant expression of HLA-DR on the surfaces of proliferating alveolar cells ( 16). We did not observe aberrant expression of HLA-DR on endothelial or specialized cells. It is interesting that the mechanisms for induction of M H C class I1 on endothelial or specialized cell surfaces differ from the technical advice and Dr. Donald Reay, Chief Medical Examiner, mechanisms of induction on macrophages.
King County, Washington, for making the control tissue speciEpithelial and bronchial tissues obtained from normal adults mens available. have been found to express variable amounts of HLA-DR antigen (17, 18) . In contrast, we noted an absence of positive-staining
